Login

Calquence 100 mg hard capsules *
Pharmacy Only: Prescription

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC

  • Status:

    Updated

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

  • Active Ingredient(s):

    Acalabrutinib

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

  • What is a Patient Information Leaflet and why is it useful?

    A Patient Information Leaflet (PIL) is the leaflet for patients containing information on taking a medicine, that is included with the medicine packaging. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean that the version on medicines.ie may differ from the version found with your medicine. You can compare the “Leaflet prepared or revised date” towards the end of the leaflet in the pack with the version that is on the website to find out if there have been any changes to the information since your medicine was packed.

  • 20201105 Package Leaflet IE MT Calquence MAA ONC 20 0028

    Last updated: 30/09/21